Finding 1227860 (2023-007)

Material Weakness Repeat Finding
Requirement
H
Questioned Costs
-
Year
2023
Accepted
2026-08-26
Audit: 409789
Organization: Island Health, Inc. (MA)
Auditor: COHNREZNICK LLP

AI Summary

  • Core Issue: The Center failed to review and approve expenditures within the grant's period of performance, risking non-compliance with federal regulations.
  • Impacted Requirements: Expenditures must only include allowable costs during the approved budget period as per federal guidelines (2 CFR sections 200.308, 200.309, 200.403(h)).
  • Recommended Follow-Up: Establish written procedures to ensure all expenditures are reviewed and approved for compliance with the grant's period of performance.

Finding Text

Finding 2023.007: Period of Performance - Material Weakness Name of Federal Agency: U.S. Department of Health and Human Services Federal Program Names: Health Center Program Cluster Health Center Program (Community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) COVID -19 Health Center Program (Community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) Grants for New and Expanded Services under the Health Center Program COVID-19 Grants for New and Expanded Services under the Health Center Program Federal Assistance Listing Number: 93.224 and 93.527 Federal Award Identification Number and Year: H8026638 - 2022 and 2023, H8F40829 - 2021 and H8G48040-2023 Criteria A non-federal entity may charge only allowable costs incurred during the approved budget period of a federal award's period of performance that were authorized by the federal awarding agency or pass-through entity (2 CFR sections, 200.308, 200.309 and 200.403(h)). Condition There was no evidence of the Center's review and approval of the period of performance for expenditures during the year. Cause The Center did not have adequate controls to review period of performance to ensure all goods and services are appropriately included or excluded. Effect or Potential Effect The Center may incur expenditures to the grant that are not within the grant's period of performance. Questioned Costs None. Context We selected 8 payroll transactions charged to the federal program to test controls over period of performance and noted 8 instances where there was no formal approval of the cost charged to the major program by evidence of a review. Identification of Repeat Finding Yes, see finding 2022.007. Recommendation The Center should develop written procedures to review all expenditures to ensure they are within the proper period of performance of the grant. Views of Responsible Officials Management and the Board of Directors agree with the finding and will implement additional controls to ensure there is formal evidence of approval over the period of performance for goods and services purchased under the grant.

Corrective Action Plan

Item 2023.007 – Period of Performance Recommendation The Center should develop written procedures to review all expenditures to ensure they are within the proper period of performance of the grant. Repeat Finding Yes Action Taken Island Health Care will take the following actions to address this recommendation: • Conduct a pre-approval of expenditures, verifying that the expense is allowable under the grant terms and falls within the period of performance • Utilize a pre-approval form that includes details of the proposed expenditure, its necessity, and confirmation in the form of authorized signatures that it is within the grant period. • Require all relevant supporting documentation with the date the expense was incurred, ensuring it falls within the grant's period of performance. This is further reviewed by the CFO who will verify that the expenditure meets all requirements and is then able to record it in the accounting system. • Conduct regular reviews of expenditures to ensure compliance with the grant period and maintain audit trail • Review these procedures annually to ensure they ongoing compliance with the grant's period of performance

Categories

Procurement, Suspension & Debarment Subrecipient Monitoring Allowable Costs / Cost Principles HUD Housing Programs Material Weakness Period of Performance Matching / Level of Effort / Earmarking

Other Findings in this Audit

  • 1227841 2023-003
    Material Weakness Repeat
  • 1227842 2023-004
    Material Weakness Repeat
  • 1227843 2023-005
    Material Weakness Repeat
  • 1227844 2023-006
    Material Weakness Repeat
  • 1227845 2023-007
    Material Weakness Repeat
  • 1227846 2023-003
    Material Weakness Repeat
  • 1227847 2023-004
    Material Weakness Repeat
  • 1227848 2023-005
    Material Weakness Repeat
  • 1227849 2023-006
    Material Weakness Repeat
  • 1227850 2023-007
    Material Weakness Repeat
  • 1227851 2023-003
    Material Weakness Repeat
  • 1227852 2023-004
    Material Weakness Repeat
  • 1227853 2023-005
    Material Weakness Repeat
  • 1227854 2023-006
    Material Weakness Repeat
  • 1227855 2023-007
    Material Weakness Repeat
  • 1227856 2023-003
    Material Weakness Repeat
  • 1227857 2023-004
    Material Weakness Repeat
  • 1227858 2023-005
    Material Weakness Repeat
  • 1227859 2023-006
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.224 Community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care $365,690
21.027 CORONAVIRUS STATE AND LOCAL FISCAL RECOVERY FUNDS $209,873
93.268 IMMUNIZATION COOPERATIVE AGREEMENTS $103,743
93.526 GRANTS FOR CAPITAL DEVELOPMENT IN HEALTH CENTERS $54,138
93.527 GRANTS FOR NEW AND EXPANDED SERVICES UNDER THE HEALTH CENTER PROGRAM $41,299